Northwestern University scientists have uncovered a hidden molecular "control switch" inside a protein that helps the body ...

CARDINAL Phase 1/2 trial of TERN-701 enrolling well, with multiple important milestones in 2026Planned milestones include pivotal dose selection, ...

LoQus23 Therapeutics nominates LQT-23 as first-in-class, oral drug candidate for Huntington’s Disease LQT-23 is a potent, highly differentiated, first-in-class allosteric small molecule inhibitor of ...

A research team presents an overview of recent advances in the microbial biosynthesis of L-tryptophan (L-Trp) and its ...

Northwestern University scientists have uncovered a hidden molecular "control switch" inside a protein that helps the body ...

The psoriasis market is experiencing steady growth, driven by rising disease prevalence, improved diagnosis rates, and ...

Both Phase 3 trials met all primary and secondary endpoints with high statistical significance in patients with moderate-to-severe plaque ...

Northwestern University scientists have uncovered a hidden molecular "control switch" inside a protein that helps the body sense taste, control blood sugar and defend the gut.

This review synthesizes progress in pathway optimization, regulatory rewiring, and microbial cell factory design that has ...

The psoriasis market is experiencing steady growth, driven by rising disease prevalence, improved diagnosis rates, and greater patient access to advanced therapies. The shift from conventional ...

It is cold season. A homonym if there ever was one. As I cannot control the temperature, allow me to give you some advice on ...